John Taylor, the FDA’s acting principal deputy commissioner, says, "We recognize that third-party inspection programs need to be a bigger part of the discussion because we can’t do all the work ourselves. We’re looking at anything, anything and everything that will allow us to leverage our resources better."
Return Home: http://drughealth.blogspot.com/
No comments:
Post a Comment